NTHI

NeOnc Technologies Holdings, Inc.
CAPPED RATING

NeOnc Technologies Holdings, Inc. (NTHI) is rated C- (2.0/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Value (F). The rating has held at C- for 4 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.0 / 5.0
C-
Value
F
Factor Score 0.0 / 5.0
Growth
C
Factor Score 2.2 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
C-
Factor Score 2.1 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -4.9
EV / EBITDA N/A
Rev Growth YoY N/A
Gross Margin N/M
Price Return 3M 14.9%
Price Return 12M -57.5%
Catalyst Signal 0.00
Market Cap $139.9M
TTM Revenue $40.0K
Price / Sales 3.5K
ROE N/A

Historical Factor Score Progression

Held C- for 4 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 F (0.0) C (2.2) B- (3.0) C- (2.1) C+ (2.6) C- (2.0)
2026-11-06 F (0.0) C- (2.1) B- (3.0) D+ (1.8) C+ (2.7) C- (1.9)
2026-10-30 F (0.0) C- (2.1) B- (3.1) C- (2.1) C+ (2.7) C- (2.0)
2026-10-23 F (0.0) C- (2.0) B- (3.1) D+ (1.8) C+ (2.6) C- (1.9)
2026-10-16 F (0.0) C- (2.0) B- (3.1) D+ (1.7) C+ (2.6) C- (1.9)
Page 1 of 4